HHS officials discredited international reference pricing in speeches and articles for years before coming to work for the Trump administration, where they are now proposing to rely on foreign price controls to set prices in the United States. The former policy positions of HHS Secretary Alex Azar and FDA Commissioner Scott Gottlieb leads some observers to believe the Trump administration officials are using the International Pricing Index proposal as a bluff to get drug makers to come up with less...